Lien Lippens

PhD Thesis

Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles

Lien Lippens (UGent)

(2022)

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2022) CANCER IMMUNOLOGY IMMUNOTHERAPY.

Add to list

Journal Article
A1
open access

Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer

Teodora-Eugenia Oltean (UGent) , Lien Lippens (UGent) , Kelly Lemeire (UGent) , Caroline De Tender (UGent) , Marnik Vuylsteke, Hannelore Denys (UGent) , Katrien Vandecasteele (UGent) , Peter Vandenabeele (UGent) and Sandy Adjemian Catani (UGent)

(2022) FRONTIERS IN ONCOLOGY. 12.

Add to list

Conference Paper
C3
open access

Automated liquid handling for highly specific and reproducible density‐based separation of extracellular vesicles from human body fluids

Sofie Van Dorpe (UGent) , Lien Lippens (UGent) , Robin Boiy (UGent) , Hannelore Denys (UGent) , Olivier De Wever (UGent) and An Hendrix (UGent)

(2021) JOURNAL OF EXTRACELLULAR VESICLES. In Journal of Extracellular Vesicles 10(S1).

Add to list

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450

Add to list

Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables

Edward Geeurickx, Lien Lippens (UGent) , Pekka Rappu, Bruno De Geest (UGent) , Olivier De Wever (UGent) and An Hendrix (UGent)

(2021) NATURE PROTOCOLS. 16(2). p.603-633

Add to list

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo, Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343

Add to list

Journal Article
A1
open access

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine

Bert Dhondt (UGent) , Edward Geeurickx, Joeri Tulkens, Jan Van Deun (UGent) , Glenn Vergauwen (UGent) , Lien Lippens (UGent) , Ilkka Miinalainen, Pekka Rappu, Jyrki Heino, Piet Ost (UGent) , et al.

(2020) JOURNAL OF EXTRACELLULAR VESICLES. 9(1).

Add to list

Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Sofie De Geyter (UGent) , Koen Van de Vijver (UGent) , An Hendrix (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2020) International Journal of Cancer.

Add to list

Journal Article
A1
open access

Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

Joeri Tulkens, Glenn Vergauwen (UGent) , Jan Van Deun (UGent) , Edward Geeurickx, Bert Dhondt (UGent) , Lien Lippens (UGent) , Marie-Angélique De Scheerder (UGent) , Ilkka Miinalainen, Pekka Rappu, Bruno De Geest (UGent) , et al.

(2020) GUT. 69(1). p.191-193

Academic Bibliography

Lien Lippens

Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer

Automated liquid handling for highly specific and reproducible density‐based separation of extracellular vesicles from human body fluids

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine

Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

Contents

Support

Contact